ATB-346 Uses, Dosage, Side Effects and more
ATB-346 is under investigation in clinical trial NCT03220633 (Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects).
| Attribute | Details |
|---|---|
| Trade Name | ATB-346 |
| Generic | ATB-346 |
| Type | |
| Formula | C21H19NO3S |
| Weight | Average: 365.45 Monoisotopic: 365.10856465 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
